UTHSC In the Media


Dr. Arindam Bagchi joins Darryl Worley Cancer & Infusion Center as Full-Time Medical Oncologist

In the Media Icon

Hardin Medical Center is proud to announce that Arindam Bagchi, MD, has officially joined the Darryl Worley Cancer & Infusion Center as its full-time medical oncologist, providing comprehensive cancer and hematology care Monday through Friday to patients across the region.


Medical Schools Expand Nutrition Requirements Under HHS Initiative

In the Media Icon

Nineteen additional medical schools have agreed to require at least 40 hours of nutrition education beginning this fall, expanding a federal initiative that seeks to make nutrition training a more prominent component of physician education amid rising rates of chronic disease.


New dental continuing education program launches at Kingsport Center for Higher Education

In the Media Icon

Kingsport city leaders celebrated the launch of a new continuing education program at the Kingsport Center for Higher Education.


New dental continuing education program launches at Kingsport Center for Higher Education

In the Media Icon

Kingsport city leaders celebrated the launch of a new continuing education program at the Kingsport Center for Higher Education.


New dental continuing education program launches at Kingsport Center for Higher Education

In the Media Icon

Kingsport city leaders celebrated the launch of a new continuing education program at the Kingsport Center for Higher Education.


Marquis Who’s Who Honors William Paul Buckley, MD, FACP, for Excellence in Healthcare

In the Media Icon

William Paul Buckley, MD, FACP, brings more than 20 years of leadership experience in internal medicine to his role as a physician with Privia Health.


Agios Pharmaceuticals Touts Mitapivat Gains Despite Sickle Cell Pain Miss

In the Media Icon

Agios Pharmaceuticals (NASDAQ:AGIO) used an investor webcast tied to the 2026 European Hematology Association Congress in Stockholm to highlight new clinical data for mitapivat across thalassemia and sickle cell disease, while outlining a broader rare disease strategy that now includes multiple hematology and metabolic programs.


Agios Pharmaceuticals Touts Mitapivat Gains Despite Sickle Cell Pain Miss

In the Media Icon

Agios Pharmaceuticals (NASDAQ:AGIO) used an investor webcast tied to the 2026 European Hematology Association Congress in Stockholm to highlight new clinical data for mitapivat across thalassemia and sickle cell disease, while outlining a broader rare disease strategy that now includes multiple hematology and metabolic programs.